+Vote!
Contract Pharma Breaking News (Free subscription) | 06/10/2008
Perrigo Co. has acquired Laboratorios Diba, S.A. for approximately $25 million in cash. Based in Guadalajara, Mexico, Laboratorios Diba is a store brand manufacturer of OTC and prescription pharmaceuticals, including antibiotics, hormonals and opthalmics. The acquisition is expected to add nearly $15 million of annual sales. Perrigo's chairman and chief executive officer, Joseph C. Papa stated, "Perrigo...
+Vote!
PR News Wire (Free subscription) | 03/10/2008
ALLEGAN, Mich., Oct. 3 /PRNewswire-FirstCall/ -- Perrigo Company
(Nasdaq: ;TASE) announced today that Perrigo Chairman and CEO Joseph C.
Papa will present at the JMP Securities 2008 Healthcare Focus Conference on
Monday, October 6, at 9:30 a.m. (ET) at the Le Parker Meridien Hotel in New
York. The presentation will be webcast on the following link
.
Perrigo Company is a leading global healthcare...
+Vote!
Business Wire (Free subscription) | 02/10/2008
CHICAGO--(BUSINESS WIRE)--Four free stock picks are being made available today on Zacks.com. The industry’s leading independent research firm highlights one
+Vote!
PR News Wire (Free subscription) | 18/09/2008
ALLEGAN, Mich., Sept. 18 /PRNewswire-FirstCall/ -- The Perrigo Company
(Nasdaq: ; TASE) announced today that the Hatch-Waxman litigation
relating to Miconazole Nitrate Vaginal Cream and Suppository between
Johnson & Johnson and Perrigo has been dismissed. Earlier this year,
Perrigo had been sued by Johnson & Johnson's McNeil unit for infringement
of a patent related to Perrigo's filing of an ANDA for...
+Vote!
EmailWire.Com (Free subscription) | 18/09/2008
(EMAILWIRE.COM, September 18, 2008 ) DALLAS, Texas - Today's Trade Alerts include: Idearc Inc. (NYSE: IAR), Cameron International Corp. (NYSE: CAM), Perrigo Co. (Nasdaq: PRGO), Union Pacific Corp. (NYSE: UNP), Wyeth (NYSE: WYE) and IDEX Corp. (NYSE: IEX). Idearc Inc. (IAR) shares closed yesterday...
- send to a friend
-
Explore : Cameron International, Computer industry, Exploration and Equipment, Money, NASDAQ, New York Stock Exchange, Railroads, Semi-Conductors, Stock exchange, Transportation, Union Pacific
+Vote!
Nutraceuticals World Breaking News (Free subscription) | 16/09/2008
In a move that is expected to boost annual sales by more than $70 million, Perrigo Company, Allegan, MI, has acquired JB Laboratories, Holland, MI, for approximately $44 million in cash. Privately-held JB Laboratories is a contract manufacturer of over-the-counter (OTC) and nutrition products for leading healthcare suppliers in the U.S. "The acquisition of JB Laboratories will further expand our high-quality...
+Vote!
PR News Wire (Free subscription) | 15/09/2008
ALLEGAN, Mich., Sept. 15 /PRNewswire-FirstCall/ -- Perrigo Company
(Nasdaq: ; TASE) announced today that Judy Brown, Perrigo's CFO will
present at the Merrill Lynch Global Pharmaceutical Conference on Tuesday,
September 16 at the Merrill Lynch Financial Centre in London.
Perrigo Company is a leading global healthcare supplier that develops,
manufactures and distributes over-the-counter (OTC) and...
+Vote!
Business Wire (Free subscription) | 12/09/2008
CHICAGO--(BUSINESS WIRE)--Four free stock picks are being made available today on Zacks.com. The industry’s leading independent research firm highlights one
+Vote!
PR News Wire (Free subscription) | 08/09/2008
ALLEGAN, Mich., Sept. 8 /PRNewswire-FirstCall/ -- Perrigo Company
(Nasdaq: ; TASE) announced today that it has acquired the exclusive
U.S. rights to sell and distribute Levocetirizine tablets, the generic
version of UCB's Xyzal(R) tablets, from Synthon Pharmaceuticals, Inc.
Synthon believes it has a first to file ANDA application for the generic
that can entitle it to 180 days of generic exclusivity...
+Vote!
Seeking Alpha (Free subscription) | 21/08/2008
John C. Lee submits: On August 18 before the market open, Perrigo (PRGO) announced Q4 earnings of $0.29 per share or $27.5 million vs. $0.20 per share or $18.8 million a year ago (see conference call transcript ). Excluding charges (impairment, improvement, restructuring, in-process R & D write off), PRGO reported $0.39 per share, missing analysts’ expectations of $0.41 per share. However, revenue...
+Vote!
Market Watch (Free subscription) | 18/08/2008
NEW YORK (MarketWatch) -- Perrigo Co. said Monday that its fourth-quarter profit rose to $27.5 million, or 29 cents a share, from $18.8 million, or 20 cents per share, in the same quarter a year before. Excluding charges, fourth-quarter adjusted profit was 39 cents a share compared to the year-earlier 24 cents. Analysts had expected earnings of 41 cents per share, according to a FactSet Research poll....
